Additionally, our in vivo experiments confirmed that knockdown of ERRFI1, a key gene within the STING signature (STINGsig), significantly enhances antitumor immunity and synergizes with α-PD1 therapy in a lung cancer model. The gene discussed is STING1; the disease is lung carcinoma.